News

Press Releases

Sep 27, 2023

CRISPR Therapeutics to Present at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting

Sep 07, 2023

CRISPR Therapeutics Announces Leadership Transition

Aug 30, 2023

CRISPR Therapeutics to Participate in Citi's 18th Annual Biopharma Conference

Aug 07, 2023

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2023 Financial Results